Genomic Determinants of Response to Trimodality Therapy for Muscle-Invasive Bladder Cancer

被引:0
|
作者
Kamran, S. C. [1 ]
Zhou, Y. [2 ]
Otani, K. [3 ]
Drumm, M. R. [1 ]
Otani, Y. [4 ]
Wu, S. [5 ]
Wu, C. L. [5 ]
Borger, D. [6 ]
Lennerz, J. K. [5 ]
Van Allen, E. M. [7 ]
Willers, H. [8 ,9 ]
Hong, T. S. [1 ]
Liu, Y. [10 ]
Davicioni, E. [11 ]
Gibb, E. [12 ]
Shipley, W. U. [1 ]
Mouw, K. W. [13 ]
Efstathiou, J. A. [14 ]
Miyamoto, D. T. [1 ]
机构
[1] Harvard Med Sch, Dept Radiat Oncol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Osaka Univ, Dept Radiat Oncol, Grad Sch Med, Suita, Osaka, Japan
[4] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[6] Takeda Oncol, Cambridge, MA USA
[7] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[10] Decipher Veractye, San Francisco, CA USA
[11] Veracyte Inc, San Diego, CA USA
[12] Veracyte Inc, Vancouver, BC, Canada
[13] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[14] Harvard Med Sch, Dept Radiat Oncol, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
137
引用
收藏
页码:S24 / S24
页数:1
相关论文
共 50 条
  • [1] Mutational Landscape and Genetic Determinants of Response to Trimodality Therapy in Muscle-Invasive Bladder Cancer
    Miyamoto, D. T.
    Kamran, S. C.
    Mouw, K. W.
    Wu, C. L.
    Wu, S.
    Ukleja, J.
    Kusaka, E.
    Otani, K.
    Borger, D.
    Lennerz, J. K.
    Van Allen, E. M.
    Willers, H.
    Hong, T. S.
    Shipley, W. U.
    Efstathiou, J. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E861 - E861
  • [2] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Johnson, Skyler B.
    Yu, James B.
    [J]. CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [3] Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Chen, Ronald C.
    Shipley, William U.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 952 - 960
  • [4] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Skyler B. Johnson
    James B. Yu
    [J]. Current Oncology Reports, 2018, 20
  • [5] Subtyping Muscle-Invasive Bladder Cancer to Assess Clinical Response to Trimodality Therapy
    Efstathiou, J. A.
    Gibb, E.
    Miyamoto, D. T.
    Wu, C. L.
    Drumm, M. R.
    Lehrer, J.
    Ashab, H. A. D. M.
    Erho, N. G.
    du Plessis, M.
    Ong, K.
    Bhat, A.
    Mouw, K.
    Davicioni, E.
    Shipley, W. U.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S118 - S118
  • [6] Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy.
    Efstathiou, Jason A.
    Gibb, Ewan
    Miyamoto, David Tomoaki
    Wu, Chin-Lee
    Drumm, Michael
    Lehrer, Jonathan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [7] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
    Nguyen, Eric K.
    Yu, Hang
    Pond, Gregory
    Shayegan, Bobby
    Pinthus, Jehonathan H.
    Kapoor, Anil
    Mukherjee, Som D.
    Neville, Alan
    Lalani, Aly-Khan A.
    Hotte, Sebastien J.
    Corbett, Thomas B.
    Dayes, Ian S.
    Lukka, Himanshu R.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
  • [8] Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Royce, Trevor J.
    Liu, Yuan
    Milowsky, Matthew, I
    Efstathiou, Jason A.
    Jani, Ashesh B.
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    [J]. CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 362 - 368
  • [9] Trimodality Therapy for Muscle-Invasive Bladder Cancer: Concurrent Chemotherapy is Not Enough
    Winquist, Eric
    Booth, Christopher M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (24) : 2709 - +
  • [10] Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Coen, John J.
    Paly, Jonathan J.
    Niemierko, Andrzej
    Kaufman, Donald S.
    Heney, Niall M.
    Spiegel, Daphne Y.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    Shipley, William U.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 311 - 316